• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov15
Reviva Pharmaceuticals Maintains Buy Rating, Target Price at $2.00
16:27
Nov14
Reviva Pharmaceuticals released FY2025 9 Months Earnings on November 13, 2025 (EST), with actual revenue of USD 0 and EPS of USD -0.3136
04:00
Reviva Pharmaceuticals released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0599 (forecast USD -0.0971)
04:00
Oct28
Reviva to present Briumvi data on negative symptoms in schizophrenia at CNS Summit
12:19
Oct24
Reviva Pharmaceuticals Holdings Inc. to Hold 2025 Annual Shareholders Meeting
20:32
Aug15
Reviva Pharmaceuticals released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1214 (forecast USD -0.12)
03:00

Schedules & Filings

Schedules
Filings
Nov13
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -4.011 M, EPS -0.0599

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -6.054 M, EPS -0.1214

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -6.433 M, EPS -0.1322

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
WSHP
200.000
+506.06%
+167.000
SGBX
6.070
+78.01%
+2.660
BACCR
0.3900
+77.27%
+0.170
SEMR
11.760
+73.96%
+5.000
PGACR
0.3500
+59.02%
+0.130
NUVB
7.150
+48.96%
+2.350
SSEAR
0.2999
+42.81%
+0.090
HXHX
0.7879
+41.15%
+0.230
CABR
1.090
+39.96%
+0.311
STEC
1.050
+38.82%
+0.294
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy